AZN | AstraZeneca PLC | $285.2b | $184.85 | +0.1% | 999.2K |
TMO | Thermo Fisher Scientific, Inc. | $258.7b | $696.06 | -0.9% | 597.2K |
DHR | Danaher Corporation | $161.8b | $231.81 | -0.7% | 860.1K |
WAT | Waters Corp | $45.2b | $456.91 | -1.3% | 255.6K |
GH | Guardant Health, Inc. Common Stock | $23.5b | $145.16 | -5.1% | 1.1M |
RVTY | Revvity, Inc. | $18.2b | $149.91 | -3.5% | 674.3K |
BBIO | BridgeBio Pharma, Inc. Common Stock | $14.4b | $77.05 | -1.6% | 473.7K |
TEM | Tempus AI, Inc. Class A Common Stock | $14.2b | $66.28 | -8.4% | 2.6M |
TECH | Bio-Techne Corp. | $11.4b | $72.80 | -0.0% | 1.8M |
KYMR | Kymera Therapeutics, Inc. Common Stock | $10.8b | $124.12 | -2.4% | 351.8K |
NUVL | Nuvalent, Inc. Class A Common Stock | $9.8b | $123.96 | 0.0% | N/A |
TWST | Twist Bioscience Corporation Common Stock | $9.3b | $105.77 | -6.5% | 1.3M |
CAI | Caris Life Sciences, Inc. Common Stock | $9.3b | $21.37 | -8.2% | 1.7M |
PRAX | Praxis Precision Medicines, Inc. Common Stock | $7.8b | $308.32 | -6.2% | 332.3K |
LNTH | Lantheus Holdings, Inc | $6.6b | $101.79 | +0.2% | 235.2K |
CDNA | CareDx, Inc. | $4.6b | $74.53 | -4.7% | 506.0K |
ADPT | Adaptive Biotechnologies Corporation Common Stock | $4.1b | $28.09 | -4.3% | 1.2M |
DYN | Dyne Therapeutics, Inc. Common Stock | $3.4b | $16.52 | -3.7% | 739.1K |
IDYA | IDEAYA Biosciences, Inc. Common Stock | $3.0b | $31.04 | -2.2% | 191.5K |
ALMR | Alamar Biosciences, Inc. Common Stock | $2.1b | $30.90 | -0.6% | 415.8K |
WGS | GeneDx Holdings Corp. Class A Common Stock | $2.0b | $51.16 | -2.8% | 485.6K |
MAZE | Maze Therapeutics, Inc. Common Stock | $1.8b | $34.26 | -0.3% | 268.7K |
CSTL | Castle Biosciences, Inc. Common Stock | $1.1b | $32.91 | -3.5% | 112.5K |
ANRO | Alto Neuroscience Inc. | $0.9b | $27.96 | -6.0% | 352.0K |
CTKB | Cytek Biosciences, Inc. Common Stock | $0.8b | $5.71 | -2.4% | 575.6K |
OABI | OmniAb, Inc. Common Stock | $0.8b | $4.89 | -0.8% | 416.5K |
AURA | Aura Biosciences, Inc. Common Stock | $0.6b | $7.19 | +1.2% | 314.0K |
NVCT | Nuvectis Pharma, Inc. Common Stock | $0.6b | $18.93 | -7.3% | 147.4K |
SOPH | SOPHiA GENETICS SA Ordinary Shares | $0.6b | $7.64 | -6.5% | 395.7K |
PRLD | Prelude Therapeutics Incorporated | $301.7m | $3.33 | -3.3% | 126.0K |
NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $299.3m | $2.23 | -5.4% | 2.2M |
QSI | Quantum-Si Incorporated Class A Common Stock | $284.5m | $1.08 | -7.8% | 3.5M |
LAB | Standard BioTools Inc. Common Stock | $241.1m | $0.62 | -11.4% | 336.3K |
BDSX | Biodesix, Inc. Common Stock | $222.1m | $9.08 | -8.2% | 156.8K |
ACIU | AC Immune SA | $207.8m | $2.06 | -4.0% | 43.6K |
XGN | Exagen Inc. Common Stock | $202.0m | $3.88 | -6.3% | 469.1K |
QTRX | Quanterix Corporation Common Stock | $139.0m | $2.84 | -3.8% | 353.9K |
FHTX | Foghorn Therapeutics Inc. Common Stock | $126.5m | $1.88 | -8.7% | 216.7K |
AVXL | Anavex Life Sciences | $111.2m | $0.84 | -10.0% | 1.2M |
SEER | Seer, Inc. Class A Common Stock | $95.8m | $1.49 | -4.8% | 108.4K |
TVGN | Tevogen Inc. Common Stock | $93.2m | $5.85 | -1.7% | 2.7K |
SERA | Sera Prognostics, Inc. Class A Common Stock | $76.1m | $1.96 | -1.0% | 5.4K |
ACRV | Acrivon Therapeutics, Inc. Common Stock | $71.6m | $1.42 | 0.0% | 200.9K |
CSBR | Champions Oncology, Inc. | $67.2m | $4.70 | 0.0% | 257 |
IBIO | iBio, Inc. Common Stock | $53.0m | $0.70 | -4.6% | 270.8K |
CCEL | Cryo-Cell International Inc. | $40.7m | $4.45 | -15.3% | 21.9K |
ALLR | Allarity Therapeutics, Inc. Common Stock | $18.0m | $0.89 | -7.9% | 161.1K |
MDXH | MDxHealth SA Ordinary Shares | $15.1m | $0.15 | -0.8% | 701.0K |
CDIO | Cardio Diagnostics Holdings Inc. Common stock | $4.7m | $1.84 | 0.0% | 11.9K |
ADVB | Advanced Biomed Inc. Common Stock | $3.6m | $2.21 | 0.0% | 31.0K |